Effect of Progesterone Administration on Severely Head Injured Patients
NCT06631547 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-06-25
Summary
To investigate the effectiveness of progesterone as a neuroprotective in patients severe traumatic brain injury in clinical outcome
Conditions
- Severe Head Trauma
Interventions
- DRUG
-
Progesterone
Hormonal treatment
- DRUG
-
The usual head trauma care
the basic treatment
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-01
- Primary Completion
- 2027-01-31
- Completion
- 2027-07-01
- FDA Drug
- Yes
More Related Trials
-
Clinical Analysis of Early Hormones Between Patients With Traumatic Brain Injury and Cerebral Hemorrhage
NCT06221215 ·Status: RECRUITING
-
Use of Cerebral Biomarkers in Minor Traumatic Brain Injury in the Emergency Unit
NCT06069674 ·Status: RECRUITING
-
Platelet Transfusion in Acute Intracerebral Hemorrhage
NCT00699621 ·Status: UNKNOWN ·Phase: NA
-
Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury
NCT04212754 ·Status: UNKNOWN
-
Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy
NCT02803112 ·Status: TERMINATED
-
The Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury
NCT00987688 ·Status: COMPLETED ·Phase: NA
-
Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
NCT00507104 ·Status: COMPLETED
-
Mild Head Injury, Antiplatelets, and Anticoagulants
NCT04741334 ·Status: COMPLETED
-
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
NCT05560373 ·Status: UNKNOWN ·Phase: PHASE4
-
Problems With Morphine Use in Patients With a Severe Brain Injury
NCT00196131 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Beta Blocker Effects in Traumatic Brain Injury
NCT05195996 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury
NCT00313716 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury
NCT00124293 ·Status: COMPLETED
-
Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury
NCT01810276 ·Status: TERMINATED ·Phase: NA
-
Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage
NCT02915380 ·Status: UNKNOWN
-
Study on the Effect of Prostacyclin Compared to Placebo in Traumatic Brain Injury
NCT01363583 ·Status: COMPLETED ·Phase: PHASE1
-
PROtein S100B for Mild Trauma of the HEad in Emergency Patients
NCT03313505 ·Status: COMPLETED
-
Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages
NCT00435006 ·Status: COMPLETED
-
OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)
NCT01589393 ·Status: COMPLETED ·Phase: NA
-
Early Propranolol After Traumatic Brain Injury: Phase II
NCT01202110 ·Status: TERMINATED ·Phase: PHASE2
-
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
NCT00222625 ·Status: UNKNOWN ·Phase: PHASE2
-
Protein Supplementation in Infants With Brain Injury
NCT01936246 ·Status: COMPLETED ·Phase: NA
-
Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury
NCT01322009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Beta Blockade in in Traumatic Brain Injury
NCT02957331 ·Status: COMPLETED ·Phase: PHASE4
-
Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency
NCT01089075 ·Status: TERMINATED ·Phase: PHASE4